FARADAY PHARMACEUTICALS, INC.
Profile
Company Names
FARADAY PHARMACEUTICALS, INC.
Addresses
1616 EASTLAKE AVENUE E., SUITE 560, SEATTLE, WA 98102
Phone Numbers
2064528700
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, OTHER
Year Incorporated:
2013
State Incorporated:
DELAWARE
Total Amount Raised:
$115,498,828.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-10-24
$52,826,124.00
$102,826,124.00
$50,000,000.00
Equity
3
2019-08-29
$25,065,950.00
$30,065,949.00
$4,999,999.00
Equity
2
2019-03-05
$5,000,000.00
$10,000,000.00
$5,000,000.00
Debt
1
2014-07-09
$32,606,754.00
$32,780,000.00
$173,246.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN
BLACKMAN
EXECUTIVE OFFICER
STEVEN
GILLIS
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TRUBION PHARMACEUTICALS, INC
| PHASERX INC
| PULMATRIX INC
| THERACLONE SCIENCES, INC.
| MIRINA CORP
| SURFACE LOGIX INC
| ACYLIN THERAPEUTICS, INC.
| BLUEBIRD BIO, INC.
| VARIATION BIOTECHNOLOGIES (US), INC.
| GROOVE BIOPHARMA CORP
| ALLOZYNE INC
| PHASERX, INC.
| VIRAL LOGIC SYSTEMS TECHNOLOGY CORP
| FARADAY PHARMACEUTICALS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| LYCERA CORP
| PULMATRIX, INC.
| NEXGENIA INC.
| CODIAK BIOSCIENCES, INC.
| VBI VACCINES INC/BC
| NOHLA THERAPEUTICS INC.
| HOMOLOGY MEDICINES, INC.
| IMMUSANT, INC.
| ONCORESPONSE INC
| EGENESIS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| ARCH VENTURE FUND XI, L.P.
| HC BIOSCIENCE, INC.
| ARCH VENTURE FUND XII, L.P.
| PHEAST THERAPEUTICS, INC.
| SONOTHERA, INC.
| PRONIRAS CORP
| ONCORESPONSE, INC
LAWRENCE
GOZLAN
DIRECTOR
PAULINA
HILL
DIRECTOR
STEPHEN
HILL
EXECUTIVE OFFICER, DIRECTOR
THOMAS
KING
DIRECTOR
TERRANCE
MCGUIRE
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, INC.
| ARSANIS, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, LLC
| 480 BIOMEDICAL, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| ICELANDIC PROVISIONS, INC.
| SEER BIOSCIENCES, INC.
| CYCLERION THERAPEUTICS, INC.
| ANKYRA THERAPEUTICS, INC.
| ADAGIO THERAPEUTICS, INC.
| FARADAY PHARMACEUTICALS, INC.
| TECTONIC THERAPEUTIC, INC.
ROBERT
NELSEN
DIRECTOR
FORGE INC
| RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)
| AGIOS PHARMACEUTICALS INC
| KILIMANJARO ENERGY, INC.
| NEUROGESX INC
| KYTHERA BIOPHARMACEUTICALS INC
| SYROS PHARMACEUTICALS, INC.
| FATE THERAPEUTICS INC
| CENEXYS, INC.
| JUNO THERAPEUTICS, INC.
| BELLEROPHON THERAPEUTICS LLC
| FARADAY PHARMACEUTICALS, INC.
| SAPPHIRE ENERGY, INC.
| UNITY BIOTECHNOLOGY, INC.
| ARIVALE INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| GRAIL, INC.
| APEX NEURO HOLDINGS, INC.
| NUTCRACKER THERAPEUTICS, INC.
| SANA BIOTECHNOLOGY, INC.
| INSITRO, INC.
| NATIONAL RESILIENCE, INC.
| MEDICAL CREATIONS, INC.
| NEUMORA THERAPEUTICS, INC.
| RIPPL CARE, INC.
| SEAPORT THERAPEUTICS, INC.
MARK
ROTH
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

